- On the semaglutide weight-management label the rule turns on your next dose: take a late dose if the next one is more than 48 hours away, skip it if not.
- Tirzepatide gives a wider window: catch up within 96 hours, and never let two doses land within 72 hours of each other.
- Two or more missed weeks is a restart conversation with your clinician, often a rung down the ladder, per the semaglutide label.
- Never double up. Both molecules are long-acting, and a stacked peak buys nothing but the side effects.
- If the same day keeps failing you, move your injection day deliberately instead of missing it accidentally.
The short answer
A missed semaglutide dose has a clean label rule: on the weight-management label, take it as soon as you notice if your next scheduled dose is more than 2 days (48 hours) away, and skip it if the next dose is less than 2 days away. A missed tirzepatide dose has its own clock: take it within 4 days (96 hours), and past that, skip it and wait for your regular day.
That is the core of it, and if you close this page now you know the two numbers that matter. The rest is the fine print worth knowing: what changes after two missed weeks, why doubling up is the one genuinely bad idea, and how to move your injection day on purpose so a busy calendar stops manufacturing missed doses in the first place.
The label rule for a missed semaglutide dose
Weekly semaglutide carries two FDA labels, and their missed-dose language differs slightly, so it is worth knowing which applies to you.
The weight-management label, current on DailyMed, frames the rule around your next dose. If a dose is missed and the next scheduled dose is more than 2 days (48 hours) away, inject as soon as possible. If the next scheduled dose is less than 2 days (48 hours) away, do not inject the missed dose; wait and resume on your regular day. The logic is simple: the label never wants two injections landing within 48 hours of each other.
The type 2 diabetes label states the same idea from the other direction: inject a missed dose as soon as possible within 5 days after the day you missed. If more than 5 days have passed, skip it and take the next dose on the regularly scheduled day. Five days late plus a normal schedule keeps the two injections at least 48 hours apart, so both labels are protecting the same buffer.
In practice, the arithmetic collapses to one habit: count the days to your next scheduled dose. More than two days out, take the late dose now. Two days or closer, let it go and stay on rhythm. Either way, you return to your normal weekly day; the schedule does not shift unless you decide to move it deliberately.
The label rule for a missed tirzepatide dose
The tirzepatide label, also current on DailyMed, gives a wider window. If a dose is missed, inject it as soon as possible within 4 days (96 hours) after the missed dose. If more than 4 days have passed, skip the missed dose entirely and inject the next dose on the regularly scheduled day.
The label pairs that window with a hard floor: never take two doses of tirzepatide within 3 days (72 hours) of each other. So a Sunday injector who remembers on Wednesday takes the dose on Wednesday and returns to Sunday, because Wednesday to Sunday is more than 72 hours. A Sunday injector who remembers on Friday skips, because the late dose and the next scheduled one would land too close together.
Note the asymmetry between the two medications. Tirzepatide's catch-up window runs to 4 days; semaglutide's weight-management rule turns on the 48-hour distance to the next dose. If you have used both medications, or you switch between them, do not carry one rule to the other. The clocks are different, and the day-by-day math changes with them.
Two or more missed doses: when titration restarts
One missed week is a scheduling event. Two or more in a row is a physiology event, because the adaptation your gut built at your current dose starts to fade when the medication does.
The semaglutide weight-management label is explicit about this: if 2 or more consecutive doses are missed, reinitiate dosage escalation at a lower dose to reduce the risk of gastrointestinal side effects. The counseling section says the same thing in plain terms, telling people who miss 2 or more consecutive weeks to contact their clinician and talk about how to restart. The tirzepatide label does not publish a multi-week restart formula, which puts the decision where it belongs anyway: with the clinician who knows your dose, your history, and how your first titration went.
What that restart looks like varies. After a two-week gap at a low dose, a clinician may simply resume. After a month away at a high dose, restarting a rung or two down the ladder is the standard, conservative move, because returning to a full maintenance dose on an unadapted stomach is how rough weeks happen. Our explainer on why titration works the way it does covers the mechanism; the short version is that dose tolerance is earned over weeks and partially expires in absence.
The honest instruction: after two or more missed doses, do not guess. Message your clinician with the dates and let the restart be a decision instead of an experiment.
Never double a dose
Whatever the gap, the answer is never two doses at once, and never two doses close together to catch up.
These are long-acting medications. Semaglutide's label notes its long half-life, roughly a week, and tirzepatide's label puts its half-life at approximately 5 days. A weekly injection therefore stacks on top of what is still circulating from the last one; that overlap is the design. Inject twice in a short window and you stack a peak on a peak, which buys you nothing on the scale and considerably raises the odds of the nausea, vomiting, and dehydration risks both labels warn about. The labels' spacing floors, 48 hours for semaglutide and 72 hours for tirzepatide, exist precisely to prevent this.
A missed week costs surprisingly little. The medication still on board carries you further than it feels like it should, and appetite effects taper rather than vanish. One skipped dose, handled by the label rule, is a footnote in a course of treatment measured in months.
Moving your injection day on purpose
If your missed doses keep happening on the same day, the problem is the day, not your memory. Both labels allow you to change your weekly injection day whenever you need, provided the spacing floors hold: at least 48 hours between semaglutide doses, at least 72 hours between tirzepatide doses.
Done deliberately, the move is one slightly short or slightly long week, and then a new rhythm. We wrote a full guide to changing your injection day around travel and shifts, with worked examples. Pairing the injection with a fixed weekly anchor, and using the reminder tools covered in our injection guide, quietly retires most missed-dose math for good.
“Missing a dose is ordinary. Guessing your way back is the mistake. Count the days, follow the label rule, and tell me if it was more than one.”
Dr. Alana Reyes, MD
When to message your clinician
Message through the portal, before your next injection, when: you have missed 2 or more consecutive doses; you are unsure which rule applies to your medication or your dose; missed doses are becoming a pattern you want to redesign around; or your first dose back brought side effects that feel louder than you remember. None of these are emergencies, and all of them resolve faster in a two-line message than in a week of guessing. At Parke, every intake and every refill is reviewed by a licensed clinician, and the portal reaches a person who can actually adjust your protocol.
Bring the specifics: which dose you are on, the date you last injected, and the date you noticed. Those three facts are usually the whole consult.
The bottom line
For a missed semaglutide dose on the weight-management label, take it if your next dose is more than 48 hours away and skip it if not. For the type 2 diabetes label, the window is 5 days. For tirzepatide, catch up within 96 hours, and never let two doses land within 72 hours of each other. After two or more missed weeks, the restart is a clinician decision, and it may begin a rung down the ladder.
These rules come from the labels of the branded, FDA-approved products, not compounded preparations, but the half-lives belong to the molecules, and the arithmetic is the same in any vial. If you are still choosing a treatment, tirzepatide and semaglutide both come with the clinician who answers this question at 9 pm, and checking eligibility takes about two minutes.
Missed semaglutide doses: frequently asked questions
What if I am 3 days late on my semaglutide shot?
Count forward, not backward. Three days late means your next scheduled dose is four days away, which is more than the 48-hour buffer the weight-management label requires, so inject the late dose now and keep your normal day. The type 2 diabetes label reaches the same answer, since three days falls inside its 5-day window.
Can I take two doses to catch up?
No. Both medications are long-acting, with half-lives near a week for semaglutide and approximately 5 days for tirzepatide, so a second dose stacks onto medication still in circulation. The labels set hard spacing floors, 48 hours for semaglutide and 72 hours for tirzepatide, because doubling raises gastrointestinal and dehydration risks without improving results. One dose, then resume your schedule.
Do I have to restart at the lowest dose after missing two weeks?
Not automatically, but do not decide alone. The semaglutide weight-management label says to reinitiate dosage escalation at a lower dose after 2 or more consecutive missed doses; the tirzepatide label leaves the restart to clinical judgment. Your clinician weighs your dose, the length of the gap, and your original titration, then picks the rung. Message first, inject second.
Medical Director at Parke. Board-certified in internal medicine, with a decade of clinical practice focused on metabolic health. She reviews every clinical claim in this journal before it publishes.
- DailyMed (NIH): current FDA-approved prescribing information for branded semaglutide 2.4 mg injection, the source for the 48-hour rule and the two-week restart instruction.
- DailyMed (NIH): FDA prescribing information for branded semaglutide injection for type 2 diabetes, the source for the 5-day missed-dose window cited above.
- DailyMed (NIH): current FDA-approved prescribing information for branded tirzepatide injection, the source for the 96-hour catch-up window and the 72-hour spacing floor.
This article is general education, not medical advice, and it is not a complete list of risks or side effects. Trial figures cited here come from studies of branded, FDA-approved products; compounded medications are prepared by state-licensed US compounding pharmacies and are not FDA-approved or evaluated for safety, effectiveness, or quality. Whether any treatment is appropriate for you is a decision made with a licensed clinician who knows your history. If you are experiencing a medical emergency, call 911. Review the important safety information on each treatment page.